Re: “Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course”

Authors:
Frederick Klauschen Institute of Pathology, Charité Medical University, Berlin, Germany (FK and HB), Institute of Pathology, University of Heidelberg Medical School, Heidelberg, Germany (AS), Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA (AS)

Search for other papers by Frederick Klauschen in
Current site
Google Scholar
PubMed
Close
 MD, PhD, MSc
,
Hendrik Bläker Institute of Pathology, Charité Medical University, Berlin, Germany (FK and HB), Institute of Pathology, University of Heidelberg Medical School, Heidelberg, Germany (AS), Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA (AS)

Search for other papers by Hendrik Bläker in
Current site
Google Scholar
PubMed
Close
 MD, PhD
, and
Albrecht Stenzinger Institute of Pathology, Charité Medical University, Berlin, Germany (FK and HB), Institute of Pathology, University of Heidelberg Medical School, Heidelberg, Germany (AS), Department of Pathology, Center for Integrated Diagnostics, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA (AS)

Search for other papers by Albrecht Stenzinger in
Current site
Google Scholar
PubMed
Close
 MD
Restricted access
  • Collapse
  • Expand
  • 1.

    Chapman JS, Asthana S, Cade L et al.. Clinical sequencing contributes to a BRCA-associated cancer rediagnosis that guides an effective therapeutic course. J Natl Compr Canc Netw 2015;13:835845.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Travis WD, Brambilla E, Burke AP et al.. WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart, 4th ed. Lyon, France: IARC Press: 2014.

  • 3.

    Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO Classification of Tumours of Female Reproductive Organs, 4th ed. Lyon, France: IARC Press: 2014.

  • 4.

    Klauschen F, Heim D, Stenzinger A. Histological tumor typing in the age of molecular profiling. Pathol Res Pract 2015;211:897900.

  • 5.

    Stenzinger A, Weichert W, Lennerz JK, Klauschen F. Basket trials: just the end of the first quarter. J Clin Oncol 2015;33:28232524.

  • 6.

    Klauschen F, Andreeff M, Keilholz U et al.. The combinatorial complexity of cancer precision medicine. Oncoscience 2014;1:504509.

  • 7.

    Heim D, Budczies J, Stenzinger A et al.. Cancer beyond organ and tissue specificity: next-generation-sequencing gene mutation data reveal complex genetic similarities across major cancers. Int J Cancer 2014;135:23622369.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 1.

    FACT SHEET: Investing in the National Cancer Moonshot [Internet]. whitehouse.gov. [cited 2016 Feb 10]. Available from: https://www.whitehouse.gov/the-press-office/2016/02/01/fact-sheet-investing-national-cancer-moonshot

    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 589 371 18
PDF Downloads 76 21 0
EPUB Downloads 0 0 0